[1] Gold E, Zellhuber-McMillan S, Risbridger G, Marino FE: Regional localization of activin-β A, activin-β C, follistatin, proliferation, and apoptosis in adult and developing mouse prostate ducts. Gene Expression Patterns 2017, 23–24:70-9..

[2] Zimmers TA, Jiang Y, Wang M, Liang TW, Rupert JE, Au ED, Marino FE, Couch ME, Koniaris LG: Exogenous GDF11 induces cardiac and skeletal muscle dysfunction and wasting. Basic Research in Cardiology 2017, 112:48.

[3] Ottley EC, Reader KL, Lee K, Marino FE, Nicholson HD, Risbridger GP, Gold E: Over-Expression of Activin-βC Is Associated with Murine and Human Prostate Disease. Hormones and Cancer 2017, 8:100-7.

[4] Marino FE, Risbridger G, Gold E: Activin‐βC modulates cachexia by repressing the ubiquitin‐proteasome and autophagic degradation pathways. Journal of cachexia, sarcopenia and muscle 2015, 6:365-80.

[5] Marino FE, Risbridger G, Gold E: Re-evaluating the role of activin-β C in cancer biology. Cytokine & growth factor reviews 2015, 26:463-70.

[6] Marino FE, Risbridger G, Gold E: Activin-β C modulates gonadal, but not adrenal tumorigenesis in the inhibin deficient mice. Molecular and cellular endocrinology 2015, 409:41-50.

[7] Marino FE, Risbridger G, Gold E: The inhibin/activin signalling pathway in human gonadal and adrenal cancers. Molecular human reproduction 2014:gau074.

[8] Marino FE, Risbridger G, Gold E: The therapeutic potential of blocking the activin signalling pathway. Cytokine & growth factor reviews 2013, 24:477-84.

[9] Gold E, Marino FE, Harrison C, Makanji Y, Risbridger G: Activin‐βc reduces reproductive tumour progression and abolishes cancer‐associated cachexia in inhibin‐deficient mice. The Journal of pathology 2013, 229:599-607.

[10] Tamburrino L, Marchiani S, Montoya M, Marino FE, Natali I, Cambi M, Forti G, Baldi E, Muratori M: Mechanisms and clinical correlates of sperm DNA damage. Asian journal of andrology 2012, 14:24.

[11] Modesti PA, Serneri GGN, Gamberi T, Boddi M, Coppo M, Lucchese G, Chiavarelli M, Bottai G, Marino F, Gensini CT: Impaired angiotensin II–extracellular signal-regulated kinase signaling in failing human ventricular myocytes. Journal of hypertension 2008, 26:2030-9.